Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nilotinib monohydrochloride monohydrate (Nilotinib (monohydrochloride monohydrate)) is significantly potent BCR-ABL against, is a second generation tyrosine kinase inhibitor (TKI), and is active against many BCR-ABL mutants.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 33.00 | |
100 mg | In stock | $ 47.00 | |
200 mg | In stock | $ 59.00 | |
500 mg | In stock | $ 117.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 30.00 |
Description | Nilotinib monohydrochloride monohydrate (Nilotinib (monohydrochloride monohydrate)) is significantly potent BCR-ABL against, is a second generation tyrosine kinase inhibitor (TKI), and is active against many BCR-ABL mutants. |
In vivo | In the indomethacin-induced enterocolitis rat model, nilotinib has a positive effect on the macroscopic and microscopic pathologic scores, ensuring considerable mucosal healing.?Nilotinib decreases PDGFR α and β levels and increases the colonic apoptotic scores[2]. |
Synonyms | Nilotinib (monohydrochloride monohydrate), AMN107 (monohydrochloride monohydrate) |
Molecular Weight | 583.99 |
Formula | C28H22F3N7O.HCl.H2O |
CAS No. | 923288-90-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33 mg/mL (56.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nilotinib monohydrochloride monohydrate 923288-90-8 Angiogenesis Autophagy Cytoskeletal Signaling Tyrosine Kinase/Adaptors Bcr-Abl AMN107 monohydrochloride Nilotinib monohydrochloride Monohydrate Nilotinib (monohydrochloride monohydrate) inhibit AMN 107 tyrosine kinase AMN107 Inhibitor AMN107 (monohydrochloride monohydrate) antitumor Nilotinib monohydrochloride AMN-107 Nilotinib inhibitor